exifone has been researched along with Cognition Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adaikkan, C; Cam, HP; Elmsaouri, S; Gao, F; Gjoneska, E; Haggarty, SJ; Huang, WC; Lee, A; Nott, A; Pan, L; Pantano, L; Pao, PC; Patnaik, D; Penney, J; Phan, TX; Tsai, LH; Wang, J; Watson, LA | 1 |
| Allain, H; Bentue-Ferrer, D; Denmat, J; Milon, D; Pape, D; Pignol, P; Reymann, JM; Sabouraud, O; Van den Driessche, J | 1 |
1 trial(s) available for exifone and Cognition Disorders
| Article | Year |
|---|---|
Randomized, double-blind trial of exifone versus cognitive problems in Parkinson's disease.
Topics: Aged; Benzophenones; Clinical Trials as Topic; Cognition Disorders; Double-Blind Method; Female; Humans; Male; Memory, Short-Term; Middle Aged; Parkinson Disease; Psychotropic Drugs; Random Allocation | 1988 |
1 other study(ies) available for exifone and Cognition Disorders
| Article | Year |
|---|---|
HDAC1 modulates OGG1-initiated oxidative DNA damage repair in the aging brain and Alzheimer's disease.
Topics: Acetylation; Aging; Alzheimer Disease; Animals; Astrocytes; Base Sequence; Benzophenones; Brain; Cognition; Cognition Disorders; DNA Damage; DNA Glycosylases; Down-Regulation; Gene Ontology; Guanine; Histone Deacetylase 1; Memory; Mice, Inbred C57BL; Mice, Knockout; Neurons; Oxidative Stress; Promoter Regions, Genetic | 2020 |